Stay updated on VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Sign up to get notified when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.

Latest updates to the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No substantive study details appear to be changed.SummaryDifference0.1%

- Check13 days agoChange DetectedPublications section now indicates entries are automatically filled from PubMed, and the page revision is updated to v3.3.1.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the government funding lapse notice at the top of the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe two screenshots show only minor UI/layout updates with no changes to core study details (inclusion criteria, outcomes, enrollment, status, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedAdded a government operating status notice and updated version to v3.2.0; removed a previous specific disease term and downgraded to v3.1.0. The update emphasizes current operating status and versioning over the deleted term.SummaryDifference5%

- Check70 days agoChange Detected- The page now shows Revision: v3.1.0 (new). - The previous Revision: v3.0.2 was removed (updated version).SummaryDifference0.1%

Stay in the know with updates to VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.